{
}
President-elect Donald Trump has appointed Robert F. Kennedy Jr., known for his controversial views on vaccines, to lead the Department of Health and Human Services. Kennedy, who previously ran for president as an independent, aims to address chronic diseases and reduce harmful chemicals in food. His appointment has raised concerns among public health advocates about potential negative impacts on health policies and vaccine regulation.
Traders are closely monitoring market movements following President-elect Trump's nomination of Robert F. Kennedy Jr. for HHS, raising vaccination concerns. Key biotech stocks like Moderna and Pfizer have seen declines, while the SPDR S&P Biotech ETF dropped 3%. In retail, Grocery Outlet and Warby Parker are up significantly, while Boeing's stock has fallen 15% since August amid labor disputes. Upcoming economic data is anticipated to influence market sentiment further.
Jim Cramer highlighted the extreme post-election market, noting sectors like enterprise software, subscription models, and banking that have surged but may need a pullback. He expressed caution over the rapid gains in stocks like Salesforce and Amazon, while also identifying pharmaceuticals and semiconductors as potentially undervalued sectors that could rebound. Cramer emphasized the need for clarity from the incoming administration before making investment decisions.
Shares of vaccine manufacturers plummeted following President-elect Donald Trump's nomination of Robert F. Kennedy Jr., a noted vaccine skeptic, to lead the Department of Health and Human Services. Moderna, Novavax, Pfizer, and BioNTech all experienced significant declines, with Moderna down over 5% and Novavax falling more than 7%. Experts warn that Kennedy's influence could amplify anti-vaccine sentiments, potentially hindering vaccination efforts in the U.S.
President-elect Donald Trump has appointed Robert F. Kennedy Jr. as the head of the Department of Health and Human Services, a decision that positions a well-known vaccine skeptic in a key federal health role. Trump emphasized the importance of protecting Americans from harmful substances, including chemicals and pharmaceuticals, which he claims contribute to the nation's health crisis. Following the announcement, vaccine stocks experienced a decline.
Canada is piloting an incentive program to combat antimicrobial resistance (AMR), with other nations like the UK and Japan exploring similar initiatives. Experts emphasize the need for a unified scientific approach to address AMR, highlighting the importance of prevention, regulation, and understanding community needs to ensure effective antibiotic use and animal health. Access to antibiotics is improving in low- and middle-income countries, but these regions are becoming hotspots for AMR, necessitating urgent action.
Pfizer Inc. is a leading global pharmaceutical company, with net sales primarily from primary care products (52.3%), specialty care products (25.6%), and oncology products (19.9%). Geographically, sales are distributed with 42.3% in the United States, 21.9% in Europe, and 33.8% in other regions.
UBS has maintained a 'Neutral' rating for Pfizer, setting a target price of 31 US dollars. Analyst Trung Huynh noted that the pharmaceutical company is starting to regain investor confidence after a mixed performance this year.
UBS has maintained a "Neutral" rating for Pfizer, setting a price target of $31 following a recent conference. Analyst Trung Huynh noted that despite a mixed performance this year, the pharmaceutical company is starting to regain investor confidence.
Pfizer is considering selling its hospital drugs unit, formed after the $17 billion acquisition of Hospira in 2015, amid pressure from activist investor Starboard Value. The unit, which includes various sterile injectables, generates around $500 million in annual EBITDA and could be valued at several billion dollars. This move follows a significant decline in Pfizer's market value and ongoing debt reduction efforts, exacerbated by supply disruptions from a tornado that damaged a key manufacturing facility.
Pfizer Inc.
Companies
The information provided herein is generated by experimental artificial intelligence and is for informational purposes only.
Trump appoints Robert F Kennedy Jr to lead health agency amid controversy
Novo Nordisk A/S
Pfizer Inc.
Moderna, Inc.
Robert F. Kennedy Jr.
Donald Trump
Michael Osterholm
Ashish Jha
James Capretta
Show more
02:13 15.11.2024
market movements and stock updates following election and health department changes
United States Dollar
Merck & Co., Inc.
Moderna, Inc.
AstraZeneca PLC
Pfizer Inc.
Boeing
Ron Baron
Ted Decker
Robert F. Kennedy Jr.
Cathie Wood
David Tepper
Show more
01:13 15.11.2024
Jim Cramer identifies market sectors needing a pullback after recent gains
Merck & Co., Inc.
Amazon.com, Inc.
Salesforce, Inc.
Spotify
Pfizer Inc.
Netflix, Inc.
Atlassian Corporation
Costco
ServiceNow, Inc.
Workday, Inc.
Datadog, Inc.
Jim Cramer
Robert F. Kennedy Jr.
Donald Trump
Show more
00:57 15.11.2024
vaccine maker stocks decline after trump nominates rfk jr for hhs
Euro
United States Dollar
Moderna, Inc.
Novavax, Inc.
GSK plc
BioNTech SE
Pfizer Inc.
USA
DEU
Robert F. Kennedy Jr.
Donald Trump
Show more
22:12 14.11.2024
Trump appoints RFK Jr. as Health Secretary amid vaccine skepticism
21:34 14.11.2024
global efforts to combat antimicrobial resistance through incentives and collaboration
Canadian Dollar
Japanese Yen
United States Dollar
British Pound Sterling
Euro
Aurobac Therapeutics
Pfizer Inc.
BEAM Alliance
GBR
CAN
ITA
JPN
SAU
Arshnee Moodley
Tamas Koncz
Khumbize Kandodo Chiponda
John-Arne Røttingen
David Reddy
Show more
21:23 14.11.2024
pfizer inc maintains strong market position with diverse product offerings
12:33 14.11.2024
ubs maintains neutral rating for pfizer with target price of 31 dollars
12:30 14.11.2024
UBS maintains neutral rating for Pfizer with price target of 31 dollars
11:42 14.11.2024
Pfizer considers divesting hospital drugs unit amid investor pressure and debt concerns
United States Dollar
The Goldman Sachs Group, Inc.
ICU Medical, Inc.
Pfizer Inc.
USA
Dave Denton
Albert Bourla
Show more
17:09 12.11.2024
Trending
Subcategory
Countries:
Companies:
Currencies:
People: